Impax Asset Management Group PLC Repligen Corp Transaction History
Impax Asset Management Group PLC
- $14.9 Billion
- Q1 2025
A detailed history of Impax Asset Management Group PLC transactions in Repligen Corp stock. As of the latest transaction made, Impax Asset Management Group PLC holds 804,511 shares of RGEN stock, worth $103 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
804,511
Previous 1,051,939
23.52%
Holding current value
$103 Million
Previous $151 Million
32.39%
% of portfolio
0.69%
Previous 0.77%
Shares
22 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
57.6MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$965 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$964 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$648 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$215 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$213 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.07B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....